<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-128204</identifier>
<setSpec>0001-7310</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Anticoagulation and Antiplatelet Therapy in Dermatology</dc:title>
<dc:description xml:lang="en">An increasing number of patients who are receiving anticoagulation or antiplatelet therapy require cutaneous surgery. Such pharmacotherapies are usually suspended based on experience in gynecologic, thoracic, and abdominal surgery. However, this practice may increase the risk of suffering a thromboembolic event. We review perioperative management of anticoagulant and antiplatelet therapy, complications associated with suspending therapy, and side effects (AU)</dc:description>
<dc:creator>Bassas, P</dc:creator>
<dc:creator>Bartralot, R</dc:creator>
<dc:creator>García-Patos, V</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Cada vez es mayor el número de pacientes que recibe tratamiento anticoagulante o antiagregante y que debe someterse a cirugía cutánea. Interrumpir estos tratamientos para prevenir el sangrado es una práctica habitual, extrapolada de las experiencias en cirugía ginecológica, torácica y abdominal. En este contexto, la suspensión de dichos tratamientos puede incrementar el riesgo de sufrir un evento tromboembólico. Realizamos una revisión sobre el manejo peroperatorio de los tratamientos anticoagulantes y antiagregantes, de las complicaciones acontecidas tras su suspensión, así como de sus efectos secundarios (AU)</dc:description>
<dc:source>Actas Dermosifiliogr;100(1): 7-16, ene. 2009. tab</dc:source>
<dc:identifier>ibc-128204</dc:identifier>
<dc:title xml:lang="es">Anticoagulación y antiagregación en Dermatología</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d932^s22020</dc:subject>
<dc:subject>^d14308^s22054</dc:subject>
<dc:subject>^d932^s22073</dc:subject>
<dc:subject>^d932^s28898</dc:subject>
<dc:subject>^d32645^s22036</dc:subject>
<dc:subject>^d22965^s22020</dc:subject>
<dc:subject>^d22965^s22073</dc:subject>
<dc:subject>^d32645^s22054</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28875^s22054</dc:subject>
<dc:subject>^d22965^s22000</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d932^s22000</dc:subject>
<dc:subject>^d22965^s28898</dc:subject>
<dc:subject>^d11622^s22054</dc:subject>
<dc:subject>^d30931^s22027</dc:subject>
<dc:subject>^d13252^s22009</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:type>article</dc:type>
<dc:date>200901</dc:date>
</metadata>
</record>
</ibecs-document>
